2030년까지 중동 및 아프리카 제약 계약 판매 조직 시장 예측 - 지역 분석 - 서비스(상업 서비스 및 비상업 서비스), 모듈(신디케이트 모듈 및 전용 모듈), 치료 영역(심혈관 장애, 종양학, 대사 장애, 신경학, 정형외과 질환, 전염병 등) 및 최종 사용자(바이오의약품 회사 및 제약 회사)
제약 계약 판매 조직(CSO) 시장의 미래 궤적은 신흥 시장으로 확장하려는 전략적 추세에 따라 뚜렷이 형성됩니다. 글로벌 제약 환경이 증가하고 신흥 경제국이 두각을 나타내면서 CSO는 아직 개발되지 않은 잠재력을 점점 더 인식하고 있습니다. 신흥 시장은 의료 인식 제고, 중산층 인구 확대, 의료 인프라에 대한 정부 투자 증가로 인해 기회를 제공합니다. 이러한 급성장하는 시장으로 사업을 확장함으로써 CSO는 증가하는 의약품 수요를 활용하고 상당한 성장이 예상되는 시장에서 조기에 강력한 발판을 마련할 수 있습니다. 그러나 이러한 확장에는 현지 규제 환경, 문화적 뉘앙스 및 다양한 의료 시스템에 대한 현명한 이해가 필요합니다. 신흥 시장으로 성공적으로 확장하려면 CSO가 각 지역의 고유한 과제와 기회에 맞게 전략을 조정해야 하는 맞춤형 접근 방식이 필요합니다. 또한, 이러한 확장은 CSO를 글로벌 의료 생태계의 중요한 역할자로 자리매김하여 매출 성장과 진화하는 시장에서 의료 접근성 및 결과를 개선하려는 더 넓은 목표에 기여합니다. 본질적으로, 신흥 시장에서의 확장을 향한 전략적 움직임은 세계화된 제약 환경의 복잡성을 헤쳐나가는 제약 CSO의 적응성과 예측을 반영하는 미래 지향적 추세로 나타납니다.
중동 및 아프리카 제약 계약 판매 조직 시장 개요
중동 및 아프리카의 제약 계약 판매 조직 시장은 사우디아라비아, 남아프리카, UAE 및 나머지 MEA 지역으로 구분됩니다. 시장 성장을 이끄는 요인으로는 디지털 기술의 통합 증가와 제품 판매 증대에 대한 제약 회사의 관심 증가 등이 있습니다. 그러나 아웃소싱과 관련된 품질 문제는 시장 성장을 방해합니다. UAE는 이 지역의 선진국으로, 인구 증가와 의약품 수요 급증으로 인해 의료 부문이 눈부신 성장을 보이고 있습니다. 진보적인 의료 부문은 제약 산업에 중요한 성장 기회를 제공합니다. UAE는 세계에서 가장 빠르게 성장하는 제약 산업 중 하나이며 첨단 기술을 수용하는 것으로도 알려져 있습니다. 두바이 산업 전략 2030 및 아부다비 비전 2030과 같은 계획은 미래 성장 전망, 수출 잠재력, 중장기 경제 영향을 고려하여 국가의 제약 부문 발전에 중점을 두고 있습니다. 과학 연구의 상당한 진전은 혁신적이고 잠재적인 약물의 개발과 생산을 촉진합니다. 제약 산업의 치열한 경쟁으로 인해 기업은 시장 선두를 유지하기 위해 가능한 한 빨리 치료제를 시장에 출시해야 합니다. 따라서 효율적인 의약품에 대한 수요 증가, 제약회사 수 증가, 전염병 및 만성질환 발생률 증가, 빈번한 제품 출시 등은 중동 및 아프리카 지역의 제약산업 발전을 뒷받침하므로 CSO 서비스 이용이 필요하게 되었습니다. 이는 해당 지역의 제약 계약 판매 조직 시장의 성장에 유리합니다.
중동 및 아프리카 제약 계약 판매 조직 시장 수익 및 예측(미화 백만 달러)
중동 및 아프리카 제약 계약 판매 조직 시장 세분화
중동 및 아프리카 제약 계약 판매 조직 시장은 분할됩니다. 서비스, 모듈, 치료 분야, 최종 사용자 및 국가로 구분됩니다.
서비스를 기준으로 중동 및 아프리카 제약 계약 판매 조직 시장은 상업 서비스와 비상업 서비스로 구분됩니다. 상업 서비스 부문은 2022년 중동 및 아프리카 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다.
모듈을 기준으로 중동 및 아프리카 제약 계약 판매 조직 시장은 신디케이트 모듈과 전용 모듈로 구분됩니다. 신디케이트된 모듈 부문은 2022년 중동 및 아프리카 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다.
치료 영역을 기준으로 중동 및 아프리카 제약 계약 판매 조직 시장은 심혈관 질환, 종양학, 대사 장애로 분류됩니다. , 신경과, 정형외과 질환, 전염병 등. 종양학 부문은 2022년 중동 및 아프리카 제약 계약 판매 조직 시장에서 가장 큰 점유율을 차지했습니다.
최종 사용자를 기준으로 중동 및 아프리카 제약 계약 판매 조직 시장은 바이오제약 회사와 제약 회사로 구분됩니다. 제약 회사 부문은 2022년 중동 및 아프리카 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다.
국가를 기준으로 중동 및 아프리카 제약 계약 판매 조직 시장은 사우디아라비아, 남아프리카, UAE로 분류됩니다. , 기타 중동 및 아프리카 지역. 사우디아라비아는 2022년 중동 및 아프리카 의약품 계약 판매 조직 시장을 장악했습니다.
Aenova Holding GmbH, IQVIA Holdings Inc, Pfizer Inc 및 Syneos Health Inc는 중동 및 아프리카 의약품 계약 판매 부문에서 운영되는 주요 회사 중 일부입니다. 조직 시장.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market - Middle East & Africa Analysis
6.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules
8.1 Overview
8.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area
9.1 Overview
9.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Country Analysis
11.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1 Saudi Arabia
11.1.1.1 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.2 UAE
11.1.2.1 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.2.3 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.2.4 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.2.5 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.3 South Africa
11.1.3.1 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.2 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.3.3 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.3.4 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.3.5 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.4 Rest of Middle East & Africa
11.1.4.1 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4.2 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.4.3 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.4.4 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.4.5 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 IQVIA Holdings Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Syneos Health Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Aenova Holding GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Pfizer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 19. Glossary of Terms, Middle East & Africa Pharmaceutical Contract Sales Organizations Market
?
List of Figures
Figure 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Middle East & Africa - PEST Analysis
Figure 3. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
1. Aenova Holding GmbH
2. IQVIA Holdings Inc
3. Pfizer Inc
4. Syneos Health Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.